Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
基本信息
- 批准号:6799971
- 负责人:
- 金额:$ 19.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-10 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:age differencecancer preventioncarcinogenesisclinical researchcooperative studygender differencehuman datalung neoplasmsneoplasm /cancer epidemiologyneoplasm /cancer typeneoplastic processneoplastic transformationracial /ethnic differencestatistics /biometrysubstance abuse epidemiologysubstance abuse related behaviortobacco abuse
项目摘要
DESCRIPTION (provided by applicant)Using the SEER database, which covers more than 10% of the US population, lung cancer incidence trends over the period 1973-1998 will be investigated using extensions of age-cohort-period models. Specifically, it is proposed to develop models in which non-specific age effects are replaced by parametric hazard functions that acknowledge the multistage nature of carcinogenesis. At least formally, this procedure finesses the well known problem of arbitrary linear trends that plagues the traditional age-cohort-period models. Furthermore, analyses of carefully collected incidence data in large registries such as SEER using biologically-based modelscan lead to insights in to the mechanisms underlying carcinogenesis in addition to shedding light on temporal trends. With respect to temporal trends, attempts will be made to relate trends in lung cancer incidence to trends in smoking habits in the US. Tobacco smoke contains both mutagens and agents that impact cell proliferation kinetics. Thus, tobacco smoke probably acts as both an initiator and a promoter in lung carcinogenesis. One goal of these analyses is to investigate whether non-specific and birth cohort and calendar year trends can be directly linked to specific aspects of carcinogenesis, such as initiation, promotion and progression. This possibility will be investigated by incorporating tobacco consumption trends into the parameters of the multistage model. Because of the large size of the SEER database it should be possible to conduct these analyses separately by race, sex and histologic type. Finally, the estimated parameters of the optimal multistage model will be used to project lung cancer incidence trends into the future under various assumptions regarding changes in composition of cigarettes and smoking habits.
描述(由申请人提供)使用SEER数据库,该数据库覆盖了超过10%的美国人口,将使用年龄-队列-时期模型的扩展研究1973-1998年期间的肺癌发病率趋势。 具体而言,它建议开发模型,其中非特定的年龄效应被替换为参数风险函数,承认多阶段性质的致癌作用。 至少在形式上,这一过程巧妙的任意线性趋势,困扰传统的年龄队列时期模型的众所周知的问题。 此外,使用基于生物学的模型对SEER等大型登记研究中仔细收集的发病率数据进行分析,除了揭示时间趋势外,还可以深入了解致癌的潜在机制。 关于时间趋势,将尝试将美国肺癌发病率趋势与吸烟习惯趋势联系起来。 烟草烟雾含有诱变剂和影响细胞增殖动力学的试剂。 因此,烟草烟雾在肺癌发生中可能既是启动剂又是促进剂。 这些分析的一个目标是调查非特异性和出生队列和日历年的趋势是否可以直接与癌症发生的特定方面,如启动,促进和进展。 将通过将烟草消费趋势纳入多阶段模型的参数来研究这种可能性。 由于SEER数据库的规模较大,因此应该可以按人种、性别和组织学类型分别进行这些分析。最后,在有关香烟成分和吸烟习惯变化的各种假设下,最佳多阶段模型的估计参数将用于预测未来肺癌发病率趋势。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SURESH H MOOLGAVKAR其他文献
SURESH H MOOLGAVKAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SURESH H MOOLGAVKAR', 18)}}的其他基金
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6545083 - 财政年份:2002
- 资助金额:
$ 19.26万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6592904 - 财政年份:2002
- 资助金额:
$ 19.26万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6950039 - 财政年份:2002
- 资助金额:
$ 19.26万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6656866 - 财政年份:2002
- 资助金额:
$ 19.26万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6751851 - 财政年份:2002
- 资助金额:
$ 19.26万 - 项目类别:
相似海外基金
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10829054 - 财政年份:2023
- 资助金额:
$ 19.26万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 19.26万 - 项目类别:
Colon cancer prevention with non-systemic PDE5 inhibitors
使用非全身性 PDE5 抑制剂预防结肠癌
- 批准号:
10484106 - 财政年份:2022
- 资助金额:
$ 19.26万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA)
在乌干达实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (CASCADE UGANDA)
- 批准号:
10544355 - 财政年份:2022
- 资助金额:
$ 19.26万 - 项目类别:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
- 批准号:
10512091 - 财政年份:2022
- 资助金额:
$ 19.26万 - 项目类别:
Gene-tobacco carcinogen interactions and lung cancer risk - a novel approach for precision cancer prevention
基因-烟草致癌物相互作用和肺癌风险——精准癌症预防的新方法
- 批准号:
10581340 - 财政年份:2022
- 资助金额:
$ 19.26万 - 项目类别:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
- 批准号:
10683294 - 财政年份:2022
- 资助金额:
$ 19.26万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA)
在乌干达实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (CASCADE UGANDA)
- 批准号:
10700084 - 财政年份:2022
- 资助金额:
$ 19.26万 - 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10563186 - 财政年份:2021
- 资助金额:
$ 19.26万 - 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10339333 - 财政年份:2021
- 资助金额:
$ 19.26万 - 项目类别: